Verition Fund Management
EBS icon

Verition Fund Management’s Emergent Biosolutions EBS Stock Holding History

Verition Fund Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-61,553
Closed -$299K – 3687
2025
Q1 		$299K Buy
61,553
+38,022
+162% +$315K ﹤0.01% 2867
2024
Q4 		$225K Buy
+23,531
New +$216K ﹤0.01% 2930
2024
Q3 		– Sell
-29,544
Closed -$201K – 3265
2024
Q2 		$201K Buy
+29,544
New +$127K ﹤0.01% 2595
2023
Q4 		– Sell
-70,274
Closed -$239K – 2416
2023
Q3 		$239K Buy
70,274
+54,916
+358% +$304K ﹤0.01% 1874
2023
Q2 		$113K Buy
+15,358
New +$142K ﹤0.01% 1961

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Verition Fund Management's EBS Position: Q2 2025 in Review

Verition Fund Management sold out of Emergent Biosolutions (EBS) in Q2 2025, closing a stake of 61,553 shares — an estimated $299K sold.

Verition Fund Management first reported a position in EBS in Q2 2023 and held it in 5 quarters. The position peaked at $299K in Q1 2025. 161 funds tracked by Wall St. Rank hold EBS as of Q2 2025.

  • Verition Fund Management reported no remaining Emergent Biosolutions position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 61,553 Emergent Biosolutions shares in Q2 2025, an estimated $299K.
  • Verition Fund Management first reported a position in Emergent Biosolutions in Q2 2023 and held it in 5 quarters.
  • Verition Fund Management's Emergent Biosolutions position peaked at $299K in Q1 2025.
  • 161 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.